Table 2. Prevalence (%) of comorbidities among patients with newly diagnosed hypertension by data source and duration of retrospective observation.

	Hospitalization only				Claims only				Hospitalization and Claims
	6M	1yr	2yrs	3yrs	6M	1yr	2yr	3yrs	6M	1yr	2yrs	3yrs
Myocardial infarction	3.3	3.8	4.5	5.0	3.9	4.3	4.9	5.3	5.0	5.6	6.5	7.0
Congestive heart Failure	2.9	3.2	3.5	3.8	4.1	4.8	5.7	6.2	5.2	5.9	6.8	7.3
Peripheral vascular disease	1.4	1.6	1.8	1.9	1.6	1.9	2.4	2.7	2.5	2.9	3.4	3.8
Cerebrovascular disease	2.5	2.7	3.0	3.1	3.9	4.4	5.2	5.7	4.5	5.1	5.8	6.4
Dementia	1.0	1.1	1.1	1.2	1.2	1.3	1.5	1.6	1.7	1.8	2.0	2.2
Chronic pulmonary disease	3.8	4.2	4.8	5.3	8.2	10.9	14.8	17.5	9.9	12.6	16.4	19.1
Connective tissue disease-rheumatic disease	0.5	0.6	0.7	0.7	0.9	1.2	1.6	1.8	1.2	1.5	1.9	2.2
Peptic ulcer disease	0.6	0.7	0.8	1.0	1.2	1.7	2.7	3.4	1.5	2.1	3.1	3.9
Diabetes with complication	0.3	0.4	0.6	0.7	0.8	0.9	1.0	1.0	1.0	1.2	1.3	1.5
Diabetes without complication	2.9	3.6	4.4	4.9	3.9	4.2	4.6	4.9	5.7	6.4	7.2	7.7
Paraplegia and hemiplegia	0.2	0.3	0.3	0.4	0.7	0.8	0.8	0.9	0.8	0.9	1.0	1.1
Renal disease	1.1	1.1	1.2	1.2	1.4	1.5	1.6	1.7	1.9	2.0	2.2	2.3
Mild liver disease	0.4	0.5	0.6	0.7	0.6	0.7	1.0	1.2	0.9	1.0	1.3	1.5
Moderate and sever Liver disease	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2
Cancer	2.0	2.2	2.6	2.9	3.9	4.6	5.6	6.3	4.2	4.9	5.9	6.7
Metastatic carcinoma	0.3	0.4	0.5	0.5	0.7	0.8	0.9	0.9	0.9	1.0	1.1	1.2
AIDS/HIV	0.01	0.01	0.01	0.01	0.03	0.03	0.04	0.04	0.03	0.03	0.04	0.04
Any one of above conditions
≥1	14.3	15.5	17.3	18.7	25.2	30.0	36.1	40.0	28.0	32.6	38.5	42.3
1~2	11.4	12.4	13.9	14.9	23.6	27.4	32	34.8	23.6	27.8	32.8	35.8
≥3	2.8	3.1	3.5	3.7	1.6	2.2	3.3	4.2	4.4	5.2	6.4	7.4